Indeed, IDH1 mutation results in gain of function to catalyze the production of hydroxyglutarate (2-HG) (4), a possible oncometabolite that is thought to influence a range of cellular programs involved in epigenetic control and various processes leading to tumor development. This evidence concerns the gene IDH1 and neoplasm.